Bioxyne Ltd Cash Flow Conversion Efficiency
Bioxyne Ltd cash flow conversion efficiency. Based on the latest financial reports, Bioxyne Ltd (BXN) has a cash flow conversion efficiency ratio of -0.064x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.29 Million ≈ $-915.87K USD) by net assets (AU$20.17 Million ≈ $14.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Bioxyne Ltd (2000–2025)
Cash flow conversion efficiency of Bioxyne Ltd from 2000 to 2025. This chart illustrates how Bioxyne Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Bioxyne Ltd (BXN) share price today for real-time trading data and today's change.
Bioxyne Ltd Cash Flow Conversion Ratio Explained
Bioxyne Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Bioxyne Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioxyne Ltd ranked by their cash flow conversion efficiency. Also see BXN company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Batulicin Nusantara Maritim Tbk PT
JK:BESS
|
0.019x |
|
Midas Minerals Ltd
AU:MM1
|
-0.189x |
|
City Lodge Hotels Ltd
JSE:CLH
|
0.194x |
|
ABC Taiwan Electronics
TWO:3236
|
0.057x |
|
Maywood Acquisition Corp. Class A Ordinary Shares
NASDAQ:MAYA
|
-0.002x |
|
Glintt
LS:GLINT
|
0.004x |
|
Pulse Seismic Inc
TO:PSD
|
0.076x |
|
Amadeus Fire AG
XETRA:AAD
|
0.015x |
Annual Cash Flow Conversion Efficiency for Bioxyne Ltd (2000–2025)
The table below shows the annual cash flow conversion efficiency of Bioxyne Ltd from 2000 to 2025. Review Bioxyne Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$11.38 Million ≈ $8.05 Million |
AU$6.28 Million ≈ $4.44 Million |
0.552x | +151.14% |
| 2024-06-30 | AU$3.30 Million ≈ $2.33 Million |
AU$-3.56 Million ≈ $-2.52 Million |
-1.079x | -1331.48% |
| 2023-06-30 | AU$15.01 Million ≈ $10.62 Million |
AU$-1.13 Million ≈ $-800.27K |
-0.075x | -105.43% |
| 2022-06-30 | AU$-364.84K ≈ $-258.15K |
AU$-506.81K ≈ $-358.60K |
1.389x | +4955.72% |
| 2021-06-30 | AU$1.93 Million ≈ $1.37 Million |
AU$53.13K ≈ $37.60K |
0.027x | +48.59% |
| 2020-06-30 | AU$2.61 Million ≈ $1.85 Million |
AU$48.25K ≈ $34.14K |
0.018x | +104.18% |
| 2019-06-30 | AU$3.14 Million ≈ $2.22 Million |
AU$-1.39 Million ≈ $-983.77K |
-0.442x | -3.07% |
| 2018-06-30 | AU$4.32 Million ≈ $3.06 Million |
AU$-1.86 Million ≈ $-1.31 Million |
-0.429x | -318.22% |
| 2017-06-30 | AU$4.13 Million ≈ $2.92 Million |
AU$-424.05K ≈ $-300.04K |
-0.103x | -145.65% |
| 2016-06-30 | AU$1.55 Million ≈ $1.10 Million |
AU$348.85K ≈ $246.84K |
0.225x | +273.10% |
| 2015-06-30 | AU$1.28 Million ≈ $908.28K |
AU$-166.77K ≈ $-118.00K |
-0.130x | -122.95% |
| 2014-06-30 | AU$1.07 Million ≈ $758.45K |
AU$606.76K ≈ $429.32K |
0.566x | -87.72% |
| 2013-06-30 | AU$-210.73K ≈ $-149.10K |
AU$-971.70K ≈ $-687.54K |
4.611x | +678.23% |
| 2012-06-30 | AU$5.89 Million ≈ $4.17 Million |
AU$-4.70 Million ≈ $-3.32 Million |
-0.797x | -29.84% |
| 2011-06-30 | AU$124.34K ≈ $87.98K |
AU$-76.37K ≈ $-54.04K |
-0.614x | -149.79% |
| 2010-06-30 | AU$123.29K ≈ $87.23K |
AU$152.07K ≈ $107.60K |
1.233x | +110.83% |
| 2009-06-30 | AU$43.15K ≈ $30.53K |
AU$-491.48K ≈ $-347.75K |
-11.391x | -751.42% |
| 2008-06-30 | AU$-623.12K ≈ $-440.90K |
AU$-1.09 Million ≈ $-770.99K |
1.749x | +128.21% |
| 2007-06-30 | AU$218.65K ≈ $154.71K |
AU$-1.36 Million ≈ $-958.87K |
-6.198x | -12.44% |
| 2006-06-30 | AU$410.58K ≈ $290.51K |
AU$-2.26 Million ≈ $-1.60 Million |
-5.512x | +71.34% |
| 2005-06-30 | AU$186.98K ≈ $132.30K |
AU$-3.60 Million ≈ $-2.54 Million |
-19.232x | -365.33% |
| 2004-06-30 | AU$1.18 Million ≈ $831.58K |
AU$-4.86 Million ≈ $-3.44 Million |
-4.133x | +19.97% |
| 2003-06-30 | AU$967.78K ≈ $684.77K |
AU$-5.00 Million ≈ $-3.54 Million |
-5.164x | -386.06% |
| 2002-06-30 | AU$4.26 Million ≈ $3.01 Million |
AU$-4.52 Million ≈ $-3.20 Million |
-1.063x | -228.39% |
| 2001-06-30 | AU$9.02 Million ≈ $6.39 Million |
AU$-2.92 Million ≈ $-2.07 Million |
-0.324x | -258.68% |
| 2000-06-30 | AU$12.43 Million ≈ $8.80 Million |
AU$-1.12 Million ≈ $-793.44K |
-0.090x | -- |
About Bioxyne Ltd
Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Onlin… Read more